ADRNY (ADRNY) Stock Price & Analysis
ADRNY (ADRNY) rose 1.30% to USD 41.29 as of June 10, 2026 at 05:16 UTC, according to Nexqual real-time market data.
ADRNY last closed at USD 40.76; the session ranged USD 40.78–41.41 on volume of 11,281 shares. Market capitalization is $36.36B, with a 52-week range of USD 32.25–50.02 (OQX). Source: Nexqual, June 10, 2026 at 05:16 UTC.
Key Statistics (as of June 10, 2026 at 05:16 UTC)
| Price | USD 41.29 |
|---|---|
| Change | ▲ 1.30% (up) |
| Previous Close | USD 40.76 |
| Open | USD 40.92 |
| Day Range | USD 40.78 – 41.41 |
| 52-Week Range | USD 32.25 – 50.02 |
| Volume | 11,281 shares |
| Market Cap | $36.36B |
| Exchange | OQX |
Technical Analysis (ADRNY)
Nexqual's technical model rates ADRNY "SELL" based on 2 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 05:16 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 29.36 (oversold) |
| vs SMA50 | Below (USD 45.42) |
| MACD | -1.29 (negative) |
Analyst Ratings (ADRNY)
Wall Street analysts rate ADRNY "None" based on 2 analysts, with a mean price target of USD 49.05 (range USD 46.4–51.7), per Nexqual as of June 10, 2026 at 05:16 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 49.05 |
| High Target | USD 51.7 |
| Low Target | USD 46.4 |
| Buy / Hold / Sell | 2 / 0 / 0 |
Earnings (ADRNY)
| Next Earnings Date | 2026-08-05 |
|---|---|
| Revenue Estimate | $23.21B |
Source: Nexqual, June 10, 2026 at 05:16 UTC.
Financials & Fundamentals (ADRNY)
| Total Revenue | $91.35B |
|---|---|
| Revenue Growth (YoY) | -4.30% |
| Gross Margin | +26.61% |
| Operating Margin | +4.04% |
| Profit Margin | +2.48% |
| ROE | +14.97% |
| Debt / Equity | 131.31 |
| Current Ratio | 0.77 |
| Total Cash | $3.87B |
| Total Debt | $19.42B |
| Free Cash Flow | $2.65B |
Source: Nexqual, June 10, 2026 at 05:16 UTC.
Financial Health Score (ADRNY)
Nexqual rates ADRNY's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 05:16 UTC.
| Growth | Mixed — Revenue +3.4% YoY (annual), slow |
|---|---|
| Profitability | Mixed — Gross margin 27%, operating 4% |
| Balance Sheet | Weak — $3.87B cash vs $19.4B debt |
| Cash Flow | Mixed — FCF $2.65B, slim 2.9% margin |
| Efficiency | Mixed — ROE 15%, ROA 4.6% |
Ownership (ADRNY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.11% |
| Shares Outstanding | 880.58M |
| Float | 870.95M |
Source: Nexqual, June 10, 2026 at 05:16 UTC.
Leadership (ADRNY)
ADRNY is led by Frans W. H. Muller (age 64), President, CEO & Chairman of Management Board, per Nexqual as of June 10, 2026 at 05:16 UTC.
| President, CEO & Chairman of Management Board | Frans W. H. Muller (age 64) |
|---|---|
| CFO & Member of Management Board | M. Jolanda Poots-Bijl RC (age 56) |
| Chief Technology Officer | Jan Brecht (age 53) |
| Global Senior Vice President of Health & Sustainability | Daniella Vega |
Major Backers & Investors (ADRNY)
Notable institutional backers of ADRNY include Pacer Advisors, Inc., according to Nexqual as of June 10, 2026 at 05:16 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Pacer Advisors, Inc. | 0.13% |
Source: Nexqual, June 10, 2026 at 05:16 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AHODF | Koninklijke Ahold Delhaize N.V. | USD 43.66 | ▲ 6.23% |
| CABGY | Carlsberg AS | USD 26.16 | ▲ 3.03% |
| DANOY | Danone | USD 15.01 | ▲ 1.21% |
| BDRFY | Beiersdorf AG | USD 16.3 | ▲ 1.24% |
| VCISY | Vinci SA | USD 35.34 | ▼ 0.53% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:16 UTC. This page is informational and not investment advice.